You are here

Article Text

Article menu
Download PDFPDF
Uterine Cancers
Management of Endometrial Hyperplasia: A Survey of Members of the Korean Gynecologic Oncology Group
  1. Mi Kyoung Kim, MD*,
  2. Seok Ju Seong, MD, PhD*,
  3. Jae-Weon Kim, MD, PhD†,
  4. Duk-Soo Bae, MD, PhD‡,
  5. Seob Jeon, MD, PhD§,
  6. Sang-Hoon Kwon, MD, PhD∥ and
  7. Taek Sang Lee, MD, PhD
  1. *Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University;
  2. †Department of Obstetrics and Gynecology, Seoul National University Hospital;
  3. ‡Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University, Seoul;
  4. §Department of Obstetrics and Gynecology, Soonchunhyang University Cheonan Hospital, Cheonan;
  5. ∥Department of Obstetrics and Gynecology, Keimyung University, School of Medicine, Daegu; and
  6. Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center, Seoul, Korea.
  1. Address correspondence and reprint requests to Seok Ju Seong, MD, PhD, Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, 650-9 Yeoksam-1 Dong, Gangnam-gu, Seoul 135-081, Korea. E-mail: sjseongcheil{at}naver.com.

Abstract

Objectives This study aimed to investigate the current management of endometrial hyperplasia (EH) in Korea.

Materials and Methods This was an electronic survey, which included 40 questions, that was distributed to the members of the Korean Gynecologic Oncology Group in 2014.

Results In total, 50 (69%) of 72 members responded to the survey. The oral progestogens were the most popular choices for managing EH without atypia (simple hyperplasia(SH), 64%; complex hyperplasia (CH), 52%). In the case of CH with atypia, most of the gynecologist respondents would perform hysterectomy (95.9%). For fertility preservation, the oral progestogens were the most popular choices (SH, 75.5%; CH, 56.3%), followed by the levonorgestrel-releasing intrauterine system (LNG-IUS). More than 70% of the respondents reported use of dilatation and curettage as a follow-up method.

Conclusions Our survey results show that most of Korean gynecologic oncologists still prefer oral progestogens for conservative management of EH, notwithstanding the many successful reports on the LNG-IUS. As a follow-up evaluation method, dilatation and curettage is mostly used. To identify the optimum therapy, a randomized controlled trial comparing the LNG-IUS with continuous oral progestogens is required. Furthermore, a large-scale prospective study to confirm the most reliable technique for follow-up evaluation is necessary.

  • Endometrial hyperplasia
  • Survey
  • LNG-IUS
  • Progestogens

https://doi.org/10.1097/IGC.0000000000000483

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • The authors declare no conflicts of interest.